Clinical trialNCT06289647WithdrawnPhase 4Interventional

Azithromycin Reduction to Reach Elimination of Trachoma B

SponsorUniversity of California, San FranciscoEnrollment0Trachoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators propose a randomized controlled trial of discontinuation versus continuation of annual mass azithromycin distribution in hypoendemic communities of Maniema, DRC. The investigators will randomize communities with up to 20% Trachomatous Inflammation - Follicular (TF) prevalence following at least 5 years of mass azithromycin distribution to discontinuation or continuation of 3 additional years of annual mass azithromycin distribution.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Catherine Oldenburg, ScD, MPH
University of California, San Francisco
Principal Investigator
clinicaltrials.gov ↗
Elodie Lebas, RN
University of California, San Francisco
Study Director
clinicaltrials.gov ↗
Thomas Lietman, MD
University of California, San Francisco
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Democratic Republic of the Congo

University of California, San Francisco
Kindu, Maniema Province, Democratic Republic of the Congo

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Azithromycin →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2024
Primary completion: 31 Aug 2029
Completion: 31 Aug 2029
Last update posted: 13 Mar 2026
Registered enrollment: 0
Registry id: NCT06289647

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.